Novartis AG
NVS
$111.88
$0.460.41%
| Weiss Ratings | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B- | |||
| Rating Factors | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Excellent | |||
| Growth Index | Weak | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.26 | |||
| Price History | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.06% | |||
| 30-Day Total Return | 13.97% | |||
| 60-Day Total Return | 9.13% | |||
| 90-Day Total Return | -1.92% | |||
| Year to Date Total Return | 15.17% | |||
| 1-Year Total Return | 9.22% | |||
| 2-Year Total Return | 35.33% | |||
| 3-Year Total Return | 38.75% | |||
| 5-Year Total Return | 35.71% | |||
| 52-Week High % Change | -7.48% | |||
| 52-Week Low % Change | 21.15% | |||
| Price | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $120.92 | |||
| 52-Week Low Price | $92.35 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Valuation | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 221.92B | |||
| Enterprise Value | 240.38B | |||
| Price/Earnings (TTM) | 19.02 | |||
| Earnings Per Share (TTM) | 5.88 | |||
| Earnings Per Share Growth | -17.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.33 | |||
| Price/Book (Q) | 5.02 | |||
| Enterprise Value/Revenue (TTM) | 4.65 | |||
| Price | $111.88 | |||
| Enterprise Value/EBITDA (TTM) | 12.12 | |||
| Enterprise Value/EBIT | 14.57 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.00B | |||
| Dividend Yield | 2.17% | |||
| Div. Per Share (Most Recent) | $2.43 | |||
| Dividend Per Share (TTM) | $2.43 | |||
| Payout Ratio (TTM) | 63.85% | |||
| Dividend Per Share (Most Recent) | $2.43 | |||
| Company Info | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 41 61 324 11 11 | |||
| Address | -- | |||
| Website | www.novartis.com | |||
| Country | Switzerland | |||
| Year Founded | 1996 | |||
| Profitability | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 31.89% | |||
| Profit Margin | 23.08% | |||
| Management Effectiveness | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 10.20% | |||
| Return on Equity | 26.28% | |||
| Income Statement | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 50.32B | |||
| Total Revenue (TTM) | 51.72B | |||
| Revenue Per Share | $25.81 | |||
| Gross Profit (TTM) | 38.91B | |||
| EBITDA (TTM) | 19.84B | |||
| EBIT (TTM) | 16.50B | |||
| Net Income (TTM) | 11.94B | |||
| Net Income Avl. to Common (TTM) | 11.94B | |||
| Total Revenue Growth (Q YOY) | 15.13% | |||
| Earnings Growth (Q YOY) | 6.90% | |||
| EPS Diluted (TTM) | 5.88 | |||
| EPS Diluted Growth (Q YOY) | -65.63% | |||
| Balance Sheet | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 13.35B | |||
| Cash Per Share (Q) | $6.66 | |||
| Total Current Assets (Q) | 29.70B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 44.13B | |||
| Current Ratio (Q) | 1.035 | |||
| Book Value Per Share (Q) | $22.30 | |||
| Total Assets (Q) | 102.25B | |||
| Total Current Liabilities (Q) | 28.69B | |||
| Total Debt (Q) | 31.40B | |||
| Total Liabilities (Q) | 58.12B | |||
| Total Common Equity (Q) | 44.05B | |||
| Cash Flow | NVS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.51B | |||
| Cash from Financing (TTM) | -11.74B | |||
| Net Change in Cash (TTM) | -1.93B | |||
| Levered Free Cash Flow (TTM) | 11.15B | |||
| Cash from Operations (TTM) | 17.62B | |||
